Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Revenue
Sonoma Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Revenue
$12.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$85.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45B
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$60.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
See Also
What is Sonoma Pharmaceuticals Inc's Revenue?
Revenue
12.3m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Revenue amounts to 12.3m USD.
What is Sonoma Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%
Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Sonoma Pharmaceuticals Inc have been -16% over the past three years , -8% over the past five years , and -1% over the past ten years .